|
Sign In to gain access to subscriptions and/or personal tools.
|
Spontaneous Neoplasm Incidences in Fischer 344 Rats and B6C3F1 Mice in Two-Year Carcinogenicity Studies: A National Toxicology Program Update
Joseph K. Haseman
Biostatistics Branch, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709
James R. Hailey
Laboratory of Experimental Pathology, National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709
Richard W. Morris
Analytical Sciences, Durham, North Carolina 27713
Spontaneous neoplasm rates were determined for control Fischer 344 (F344) rats and B6C3F, mice from 2-yr rodent carcinogenicity studies carried out by the National Toxicology Program (NTP). The most frequently occurring neoplasms in untreated male F344 rats were testicular adenoma (89.1%), mononuclear cell leukemia (50.5%), adrenal gland pheochromocytoma (31.9%), and pituitary gland neoplasms (30.4%). For untreated female F344 rats, the most frequently occurring neoplasms were pituitary gland neoplasms (54.2%), mammary gland fibroadenoma (41.2%), and mononuclear cell leukemia (28.1%). The most frequently occurring neoplasms in untreated male B6C3F, mice were liver adenoma/carcinoma (42.2%), lung adenoma/carcinoma (20.5%), and malignant lymphoma (8.3%). For untreated female B6C3F, mice, the most frequently occurring neoplasms were liver adenoma/carcinoma (23.6%), malignant lymphoma (20.9%), and pituitary gland adenoma/carcinoma (1.4.8%). The tumor rates observed in feeding study (untreated) and inhalation study (chamber) control rats were generally similar. The major exceptions were pituitary gland tumors and testicular adenoma in male F344 rats. The overall incidence of testicular adenoma was much lower in chamber controls (69.4%) than in feeding study controls (89.1%), whereas pituitary gland neoplasms showed the opposite trend (60.7% vs 30.4%). The most likely explanation for this difference is related to the individual housing of chamber controls and the group housing of feeding study controls. Differences in diagnostic criteria may influence reported tumor rates. To ensure consistency and comparability of tumor diagnosis from study to study, the NTP uses rigorous histopathology quality assurance and peer review procedures. Biological factors such as body weight may also affect tumor incidence. For example, increased body weights are associated with increased incidences of certain site-specific neoplasms, especially pituitary gland and mammary gland neoplasms in rats and liver tumors in mice. The presence of Helicobacter hepaticus has been associated with an increased incidence of liver neoplasms in male B6C3F, mice. Other factors that may produce differences in control tumor rates from study to study include diet, environmental factors, genetic drift, study duration, and survival differences. The NTP database provides historical control data that may be useful in the evaluation of possible chemically related changes in tumor incidence. However, it is essential that the study being evaluated be comparable to those in the NTP database with respect to those factors that are known to influence tumor occurrence.
Key Words: Tumor incidence historical control data F344 rats B6C3F mice National Toxicology Program
Toxicologic Pathology, Vol. 26, No. 3,
428-441 (1998)
DOI: 10.1177/019262339802600318

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati Twitter What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. M. Cohen, R. D. Storer, K. A. Criswell, N. G. Doerrer, V. L. Dellarco, D. G. Pegg, Z. W. Wojcinski, D. E. Malarkey, A. C. Jacobs, J. E. Klaunig, et al.
Hemangiosarcoma in Rodents: Mode-of-Action Evaluation and Human Relevance
Toxicol. Sci.,
September 1, 2009;
111(1):
4 - 18.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Keenan, S. Elmore, S. Francke-Carroll, R. Kemp, R. Kerlin, S. Peddada, J. Pletcher, M. Rinke, S. P. Schmidt, I. Taylor, et al.
Best Practices for Use of Historical Control Data of Proliferative Rodent Lesions
Toxicol Pathol,
August 1, 2009;
37(5):
679 - 693.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Kasahara, S. Yamakawa, M. Nagatani, M. Tsurukame, and K. Tamura
Spontaneous Leiomyosarcoma Arising from the Ethmoid Turbinate of a Rat
Toxicol Pathol,
February 1, 2008;
36(2):
247 - 249.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Fedrowitz and W. Loscher
Exposure of Fischer 344 rats to a weak power frequency magnetic field facilitates mammary tumorigenesis in the DMBA model of breast cancer
Carcinogenesis,
January 1, 2008;
29(1):
186 - 193.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Thomas, J. K. Haseman, J. I. Goodman, J. M. Ward, T. P. Loughran Jr, and P. J. Spencer
A Review of Large Granular Lymphocytic Leukemia in Fischer 344 Rats as an Initial Step Toward Evaluating the Implication of the Endpoint to Human Cancer Risk Assessment
Toxicol. Sci.,
September 1, 2007;
99(1):
3 - 19.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Baldrick and L. Reeve
Carcinogenicity Evaluation: Comparison of Tumor Data from Dual Control Groups in the CD-1 Mouse
Toxicol Pathol,
June 1, 2007;
35(4):
562 - 575.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Baldrick
Carcinogenicity Evaluation: Comparison of Tumor Data from Dual Control Groups in the Sprague-Dawley Rat
Toxicol Pathol,
February 1, 2005;
33(2):
283 - 291.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. B. Rogers, S. R. Boutin, M. T. Whary, N. Sundina, Zhongming Ge, K. Cormier, and J. G. Fox
Progression of Chronic Hepatitis and Preneoplasia in Helicobacter hepaticus-Infected A/JCr Mice
Toxicol Pathol,
October 1, 2004;
32(6):
668 - 677.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. H Whittaker, A. M. Gebhart, T. C. Miller, and F. Hammer
Human health risk assessment of 2-mercaptobenzothiazole in drinking water
Toxicology and Industrial Health,
July 1, 2004;
20(6-10):
149 - 163.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Shen, H. Wanibuchi, E. I. Salim, M. Wei, A. Kinoshita, K. Yoshida, G. Endo, and S. Fukushima
Liver tumorigenicity of trimethylarsine oxide in male Fischer 344 rats--association with oxidative DNA damage and enhanced cell proliferation
Carcinogenesis,
November 1, 2003;
24(11):
1827 - 1835.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H Greim, H-P Gelbke, U Reuter, H W Thielmann, and L Edler
Evaluation of historical control data in carcinogenicity studies
Human and Experimental Toxicology,
October 1, 2003;
22(10):
541 - 549.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Wolf
Characteristics of the Spectrum of Proliferative Lesions Observed in the Kidney and Urinary Bladder of Fischer 344 Rats and B6C3F1 Mice
Toxicol Pathol,
October 1, 2002;
30(6):
657 - 662.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Seely, J. K. Haseman, A. Nyska, D. C. Wolf, J. I. Everitt, and J. R. Hailey
The Effect of Chronic Progressive Nephropathy on the Incidence of Renal Tubule Cell Neoplasms in Control Male F344 Rats
Toxicol Pathol,
October 1, 2002;
30(6):
681 - 686.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
V. S. Turusov, M. Tor, R. C. Sills, G. A. Willson, R. A. Herbert, J. R. Hailey, J. K. Haseman, and G. A. Boorman
Hepatoblastomas in Mice in the US National Toxicology Program (NTP) Studies
Toxicol Pathol,
August 1, 2002;
30(5):
580 - 591.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Pace, E. Perentes, and P.-G. Germann
Pheochromocytomas and Ganglioneuromas in the Aging Rats: Morphological and Immunohistochemical Characterization
Toxicol Pathol,
June 1, 2002;
30(4):
492 - 500.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
I. C. Munro, L. A. Haighton, J. J. Hlywka, B. S. Lynch, J. Doull, and R. Kroes
Carcinogenicity Bioassay of Bisphenol A
Toxicol. Sci.,
April 1, 2002;
66(2):
356 - 356.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Ozaki, J. K. Haseman, J. R. Hailey, R. R. Maronpot, and A. Nyska
Association of Adrenal Pheochromocytoma and Lung Pathology in Inhalation Studies with Particulate Compounds in the Male F344 Rat--The National Toxicology Program Experience
Toxicol Pathol,
February 1, 2002;
30(2):
263 - 270.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Deschl, B. Kittel, S. Rittinghausen, G. Morawietz, M. Kohler, U. Mohr, and C. Keenan
The Value of Historical Control Data--Scientific Advantages for Pathologists, Industry and Agencies
Toxicol Pathol,
January 1, 2002;
30(1):
80 - 87.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
G. A. Boorman, J. K. Haseman, M. D. Waters, J. F. Hardisty, and R. C. Sills
Quality Review Procedures Necessary for Rodent Pathology Databases and Toxicogenomic Studies: The National Toxicology Program Experience
Toxicol Pathol,
January 1, 2002;
30(1):
88 - 92.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
R. W. Tennant, S. Stasiewicz, W. C. Eastin, J. H. Mennear, and J. W. Spalding
The Tg.AC (v-Ha-ras) Transgenic Mouse: Nature of the Model
Toxicol Pathol,
January 1, 2001;
29(1_suppl):
51 - 59.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Leblanc
Pathology and Tissue Sampling Protocols for Rodent Carcinogenicity Studies: Time for Revision
Toxicol Pathol,
July 1, 2000;
28(4):
628 - 633.
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. David, M. R. Moore, D. C. Finney, and D. Guest
Chronic Toxicity of Di(2-ethylhexyl)phthalate in Rats
Toxicol. Sci.,
June 1, 2000;
55(2):
433 - 443.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. G. Fox, C. A. Dangler, S. B. Snyder, M. J. Richard, and J. P. Thilsted
C-Cell Carcinoma (Medullary Thyroid Carcinoma) Associated with Multiple Endocrine Neoplasms in a Ferret (Mustela putorius)
Vet. Pathol.,
May 1, 2000;
37(3):
278 - 282.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. W. Spalding, J. E. French, S. Stasiewicz, M. Furedi-Machacek, F. Conner, R. R. Tice, and R. W. Tennant
Responses of Transgenic Mouse Lines p53+/- and Tg•AC to Agents Tested in Conventional Carcinogenicity Bioassays
Toxicol. Sci.,
February 1, 2000;
53(2):
213 - 223.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. J. Krinke, W. Kaufmann, A. T. Mahrous, and P. Schaetti
Morphologic Characterization of Spontaneous Nervous System Tumors in Mice and Rats
Toxicol Pathol,
January 1, 2000;
28(1):
178 - 192.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
R. C. Sills, J. R. Hailey, J. Neal, G. A. Boorman, J. K. Haseman, and R. L. Melnick
Examination of Low-Incidence Brain Tumor Responses in F344 Rats Following Chemical Exposures in National Toxicology Program Carcinogenicity Studies
Toxicol Pathol,
September 1, 1999;
27(5):
589 - 599.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Nyska, J. K. Haseman, J. R. Hailey, S. Smetana, and R. R. Maronpot
The Association Between Severe Nephropathy and Pheochromocytoma in the Male F344 Rat-- The National Toxicology Program Experience
Toxicol Pathol,
July 1, 1999;
27(4):
456 - 462.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
O. Katsuta, T. Doi, Y. Okazaki, Y. Wako, and M. Tsuchitani
Case Report: Spontaneous Hemangiosarcoma in the Pancreas of a Fischer Rat
Toxicol Pathol,
July 1, 1999;
27(4):
463 - 467.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Jeffers, M. Fiscella, C. P. Webb, M. Anver, S. Koochekpour, and G. F. Vande Woude
The mutationally activated Met receptor mediates motility and metastasis
PNAS,
November 24, 1998;
95(24):
14417 - 14422.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|